Your session is about to expire
← Back to Search
rTMS for Depression Post-Spinal Cord Injury
This trial will investigate the safety and efficacy of a new treatment for depression in people with spinal cord injuries.
- Spinal Cord Injury
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a Location
Who is running the clinical trial?
- You have other brain-related diseases or memory problems.You have trouble with thinking and remembering, as shown by a test called the Montreal Cognitive Assessment.You have a history of severe mental illness.You have any electronic or metal implants in your body, such as metal in your head, a cochlear implant, or a pacemaker.You have had seizures in the past or are currently taking medication for seizures.You are currently taking a medication that can cause seizures.You are pregnant, as shown by a positive pregnancy test.You have had a spinal cord injury in the cervical or thoracic area at least 6 months ago.You need to be able to move your right thumb at least a little bit to receive the approved treatment.You have been diagnosed with major depressive disorder using specific tests.You haven't taken any antidepressant or changed your psychotropic medication for at least 4 weeks before the study (6 weeks if you just started a new medication).You have been identified as having bipolar disorder through a screening questionnaire.You are not expected to live more than 1 year.You have tried to harm yourself in the past 2 years.
- Group 1: rTMS (Repetitive Transcranial Magnetic Stimulation)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does the trial permit seniors of over 70 years to participate?
"The age range criterion for this medical trial is between 18 and 70 years old."
Am I eligible to take part in this scientific experiment?
"This clinical investigation is enrolling 14 individuals with spinal cord injuries ranging from 18 to 70 years old. The following criteria must be met for consideration: age between 18 and 70, partial active movement of the right thumb (abductor pollicis brevis), no changes in psychotropic medications within a 4-6 week period prior to the trial's commencement."
What purpose does this clinical trial seek to fulfill?
"The primary aim of this clinical trial, which will be evaluated at its Baseline, Week 3 midpoint and post-treatment 5 week conclusion is to assess the safety through potential adverse events. Secondary objectives include determining how depressive symptoms have impacted an individual's quality of life with the Sheehan Disability Scale (0 - 30 score range), Craig Handicap Assessment and Reporting Tool-Short Form self-report questionnaire (19 questions) as well as a subject's subjective wellbeing via Satisfaction With Life Scale responses from 1 to 7."
Is there still room for participants in this experiment?
"Affirmative. Data on clinicaltrials.gov confirms that the trial, which was initially posted on November 1st 2022, is actively enrolling patients. The research team expects to include 14 individuals from one medical centre in this study."
What is the aggregate number of participants in this medical study?
"Affirmative. According to clinicaltrials.gov, this research endeavour is actively searching for participants. Initially posted on the 1st of November 2022 and last updated on July first 2022; the trial seeks to recruit 14 patients at a single medical site."
Share this study with friends